Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lokesh Jain

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|September 19, 2017
Dose Finding Versus Speed in Seamless Immuno-Oncology Drug DevelopmentKapil Mayawala, Archie Tse, Eric H Rubin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 14, 2012
Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathyLokesh Jain, Barjesh Chander Sharma, Praveen Sharma, et al.
Pharmacotherapy|December 25, 2009
Lack of association between excretion of sorafenib in sweat and hand-foot skin reactionLokesh Jain, Erin R Gardner, William D Figg, et al.
Journal of Gastroenterology and Hepatology|February 22, 2013
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathyLokesh Jain, Barjesh Chander Sharma, Siddharth Srivastava, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 19, 2010
Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometryLokesh Jain, Erin R Gardner, Jürgen Venitz, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Clinical and Translational Science|May 17, 2018
Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient CareBrandon Swift, Lokesh Jain, Craig White, et al.
Indian Journal of Ophthalmology|February 25, 2009
Pattern of uveitis in North East India: a tertiary eye care center studyDipankar Das, Harsha Bhattacharjee, Pankaj Kumar Bhattacharyya, et al.
Indian Journal of Ophthalmology|November 1, 2008
Indirect optic nerve injury in two-wheeler riders in northeast IndiaHarsha Bhattacharjee, Kasturi Bhattacharjee, Lokesh Jain, et al.
British Journal of Clinical Pharmacology|August 28, 2019
Pharmacokinetic-pharmacodynamic (dipeptidyl peptidase-4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once-weekly administered omarigliptinLokesh Jain, Anne S Y Chain, Daniel A Tatosian, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|September 19, 2017
Dose Finding Versus Speed in Seamless Immuno-Oncology Drug DevelopmentKapil Mayawala, Archie Tse, Eric H Rubin, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 14, 2012
Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathyLokesh Jain, Barjesh Chander Sharma, Praveen Sharma, et al.
Pharmacotherapy|December 25, 2009
Lack of association between excretion of sorafenib in sweat and hand-foot skin reactionLokesh Jain, Erin R Gardner, William D Figg, et al.
Journal of Gastroenterology and Hepatology|February 22, 2013
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathyLokesh Jain, Barjesh Chander Sharma, Siddharth Srivastava, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 19, 2010
Determination of PF-04928473 in human plasma using liquid chromatography with tandem mass spectrometryLokesh Jain, Erin R Gardner, Jürgen Venitz, et al.
Journal of Clinical Pharmacology|January 23, 2015
Canagliflozin use in patients with renal impairment-Utility of quantitative clinical pharmacology analyses in dose optimizationManoj Khurana, Jayabharathi Vaidyanathan, Anshu Marathe, et al.
Clinical and Translational Science|May 17, 2018
Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient CareBrandon Swift, Lokesh Jain, Craig White, et al.
Indian Journal of Ophthalmology|February 25, 2009
Pattern of uveitis in North East India: a tertiary eye care center studyDipankar Das, Harsha Bhattacharjee, Pankaj Kumar Bhattacharyya, et al.
Indian Journal of Ophthalmology|November 1, 2008
Indirect optic nerve injury in two-wheeler riders in northeast IndiaHarsha Bhattacharjee, Kasturi Bhattacharjee, Lokesh Jain, et al.
British Journal of Clinical Pharmacology|August 28, 2019
Pharmacokinetic-pharmacodynamic (dipeptidyl peptidase-4 inhibition) model to support dose rationale in diabetes patients, including those with renal impairment, for once-weekly administered omarigliptinLokesh Jain, Anne S Y Chain, Daniel A Tatosian, et al.
Pageof 5